Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study

Aim: The present study compared the safety, efficacy, and tolerability of the new fixed-dose combination (FDC) of telmisartan 40 mg + bisoprolol 5 mg (TBP) tablets with the existing comparator FDC telmisartan 40 mg + metoprolol succinate ER 50 mg (TMS) tablets in patients with stage 1 and stage 2 hy...

Full description

Bibliographic Details

Published in:	Indian Heart Journal
Main Authors:	Gurpreet S Wander, Bhim Ram, Satyendra Kumar Sonkar, CN Manjunath, Padmanabh Kamath, L Sreenivasamurthy, R Balamurugan, SSVV Narasinga Rao, Debabrata Roy, Prajapati Vipulkumar Bachubhai, Manjula S, Krishna Kumar M
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Telmisartan Bisoprolol Metoprolol Hypertension Fixed-dose combination
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483224000750